medigraphic.com
Órgano Oficial del Hospital Angeles Health System

2023, Number 4

<< Back Next >>

Acta Med 2023; 21 (4)

Infradialysis and infections as risk factors for hypo- and hyperglycemia in diabetic patients hospitalized on chronic hemodialysis

Landa CTL, Valdez OR, Pérez NM, Ornelas LCA, Nochebuena LA, Espinosa CR

Language: Spanish
References: 21
Page: 303-308
PDF size: 182.19 Kb.


ABSTRACT

Glucose levels vary in diabetic patients with chronic kidney disease (CKD) due to the burnt-out diabetes phenomenon. The presence of hypo and/or hyperglycemia in hospitalized patients increases morbidity and mortality. In this retrospective, observational, descriptive study, we looked for the incidence and factors associated with hypo and/or hyperglycemia episodes in a cohort of hospitalized patients. 106 patients were included; the incidence of hypoglycemia was 49.06%, and hyperglycemia 45.28%. Patients with hypoglycemia had a longer history of diabetes than those without (p = 0.0004) and/or were hospitalized for infra-dialysis (OR = 4.08, 95% CI 1.38-13.66, p = 0.016). Patients with hyperglycemia had a higher leucocyte count (p = 0.0055). These risk factors should be promptly identified in hospitalized patients to avoid hypo and/or hyperglycemia.


REFERENCES

  1. American Diabetes Association. 4. Comprehensive medical evaluation and assessment of comorbidities: standards of medical care in diabetes-2020. Diabetes Care. 2020; 43 (Suppl 1): S37-S47.

  2. de Boer IH, Caramori ML, Chan JCN, Heerspink HJL, Hurst C, Khunti K et al. Executive summary of the 2020 KDIGO Diabetes Management in CKD Guideline: evidence-based advances in monitoring and treatment. Kidney Int. 2020; 98 (4): 839-848.

  3. American Diabetes Association. 6. Glycemic targets: standards of medical care in diabetes-2020. Diabetes Care. 2020; 43 (Suppl 1): S66-S76.

  4. National Kidney Foundation. KDOQI Clinical Practice Guideline for Diabetes and CKD: 2012 update. Am J Kidney Dis. 2012; 60 (5): 850-886.

  5. Williams ME, Garg R. Glycemic management in ESRD and earlier stages of CKD. Am J Kidney Dis. 2014; 63 (2 Suppl 2): S22-S38.

  6. Park J, Lertdumrongluk P, Molnar MZ, Kovesdy CP, Kalantar-Zadeh K. Glycemic control in diabetic dialysis patients and the burnt-out diabetes phenomenon. Curr Diab Rep. 2012; 12 (4): 432-439.

  7. Abe M, Hamano T, Hoshino J, Wada A, Inaba M, Nakai S, Masakane I. Is there a "burnt-out diabetes" phenomenon in patients on hemodialysis? Diabetes Res Clin Pract. 2017;130:211-220.

  8. Alsahli M, Gerich JE. Hypoglycemia, chronic kidney disease, and diabetes mellitus. Mayo Clin Proc. 2014; 89 (11): 1564-1571.

  9. Limkunakul C, de Boer IH, Kestenbaum BR, Himmelfarb J, Ikizler TA, Robinson-Cohen C. The association of glycated hemoglobin with mortality and ESKD among persons with diabetes and chronic kidney disease. J Diabetes Complications. 2019; 33 (4): 296-301.

  10. Action to Control Cardiovascular Risk in Diabetes Study Group; Gerstein HC, Miller ME, Byington RP, Goff DC Jr, Bigger JT, Buse JB et al. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med. 2008; 358 (24): 2545-2559.

  11. ADVANCE Collaborative Group; Patel A, MacMahon S, Chalmers J, Neal B, Billot L et al. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med. 2008; 358 (24): 2560-2572.

  12. Kalantar-Zadeh K, Derose SF, Nicholas S, Benner D, Sharma K, Kovesdy CP. Burnt-out diabetes: impact of chronic kidney disease progression on the natural course of diabetes mellitus. J Ren Nutr. 2009; 19 (1): 33-37.

  13. Kovesdy CP, Park JC, Kalantar-Zadeh K. Glycemic control and burnt-out diabetes in ESRD. Semin Dial. 2010; 23 (2): 148-516.

  14. Kalantar-Zadeh K, Kopple JD, Regidor DL, Jing J, Shinaberger CS, Aronovitz J et al. A1C and survival in maintenance hemodialysis patients. Diabetes Care. 2007; 30 (5): 1049-1055.

  15. Lo C, Toyama T, Wang Y, Lin J, Hirakawa Y, Jun M et al. Insulin and glucose-lowering agents for treating people with diabetes and chronic kidney disease. Cochrane Database Syst Rev. 2018; 9 (9): CD011798.

  16. Speeckaert M, Van Biesen W, Delanghe J, Slingerland R, Wiecek A, Heaf J et al. Are there better alternatives than haemoglobin A1c to estimate glycaemic control in the chronic kidney disease population? Nephrol Dial Transplant. 2014; 29 (12): 2167-2177.

  17. Narasaki Y, Park E, You AS, Daza A, Peralta RA, Guerrero Y et al. Continuous glucose monitoring in an end-stage renal disease patient with diabetes receiving hemodialysis. Semin Dial. 2021; 34 (5): 388-393.

  18. Mitsuyama Y, Shimizu K, Komukai S, Hirayama A, Takegawa R, Ebihara T et al. Sepsis-associated hypoglycemia on admission is associated with increased mortality in intensive care unit patients. Acute Med Surg. 2022; 9 (1): e718.

  19. Russo MP, Grande Ratti MF, Giunta DH, Elizondo CM. Pacientes hospitalizados con hiperglucemia de estrés: incidencia de diabetes y mortalidad al seguimiento. Endocrinol Diabetes Nutr (Engl). 2018; 65 (10): 571-576.

  20. Gianchandani RY, Neupane S, Heung M. Hypoglycemia in Hospitalized Hemodialysis Patients With Diabetes: An Observational Study. J Diabetes Sci Technol. 2018; 12 (1): 33-38.

  21. Khan AHKY, Zakaria NF, Abidin MAZ, Lim CTS, Kamaruddin NA. Glycemic patterns and factors associated with post-hemodialysis hyperglycemia among end-stage renal disease patients undergoing maintenance hemodialysis. J ASEAN Fed Endocr Soc. 2020; 35 (1): 68-76.




2020     |     www.medigraphic.com